Aggregation Behavior of Nanoparticle-Peptide Systems Affects Autophagy

Abstract

The aggregation of nanoparticle colloidal dispersions in complex biological environments changes the nanoparticle properties, such as size and surface area, thus affecting the interaction of nanoparticles at the interface with cellular components and systems. We investigated the effect of nanoparticle aggregation on autophagy, the main catabolic pathway that mediates degradation of nanosized materials and that is activated in response to internalization of foreign nanosized materials. We used carboxylated polystyrene nanoparticles (100 nm) and altered the nanoparticle aggregation behavior through addition of a multidomain peptide, thus generating a set of nanoparticle-peptide mixtures with variable aggregation properties. Specifically, modulating the peptide concentration resulted in nanoparticle-peptide mixtures that are well dispersed extracellularly but aggregate upon cellular internalization. We monitored the effect of internalization of nanoparticle-peptide mixtures on a comprehensive set of markers of the autophagy pathway, ranging from transcriptional regulation to clearance of autophagic substrates. The nanoparticle-peptide mixtures were found to activate the transcription factor EB, a master regulator of autophagy and lysosomal biogenesis. We also found that intracellular aggregation of nanoparticle colloidal dispersions causes blockage of autophagic flux. This study provides important insights on the effect of the aggregation properties of nanoparticles on cells and, particularly, on the main homeostatic pathway activated in response to nanoparticle internalization. These results also point to the need to control the colloidal stability of nanoparticle systems for a variety of biomedical applications.

The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy

“…As demonstrated recently for other nanomedicines, the biomolecular corona can promote or prevent particle agglomeration by altering the surface properties of the particles (Figure ). , This might change circulation time, biodistribution, macrophage recognition, toxicity, release profile, targeting, or uptake kinetics. − For example, it has been demonstrated that the electrostatic interactions between cationic nanoparticles and anionic proteins in the bloodstream cause particle agglomeration, which reduces circulation times, accumulation in the target tissue, cellular uptake, and/or endosomal escape. , This protein-induced aggregation in the blood and resulting rapid clearance is one of the major bottlenecks for the efficient use of lipoplexes (composed of permanently cationic lipids), which are characterized by a high positive global net charge . One strategy to increase nanoparticle stability in circulation is surface modification with polyethylene glycol (PEG) .…”

<p>Size-Dependent Interactions of Lipid-Coated Gold Nanoparticles: Developing a Better Mechanistic Understanding Through Model Cell Membranes and in vivo Toxicity</p>

“…It is well known that nanomaterials are taken up into cells into lysosomal compartments where the pH is 5 and cellular level interactions can induce changes in the physicochemical properties of the NPs, changes physiological structure of the cell and its behavior, and toxicity. [82][83][84][85] To evaluate the stability of the AuNPs under varying pH conditions, the acidity was adjusted with 2 M HCl (aq) and the change in O.D. was monitored by UV-Vis spectroscopy.…”

Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems

“…Investigation of molecular signaling pathways reveals that silica NPs are capable of inducing impairment in autophagy, resulting in apoptotic cell death in alveolar epithelial cells [332]. It appears that the aggregation of NPs after cell internalization negatively influences autophagy [333]. The modulatory effect of nanocarriers on autophagy can mediate their anti-inflammatory activity.…”